13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
|
Name |
WKN |
Börse |
Kurs |
Datum/Zeit |
Diff. |
Diff. % |
Geld |
Brief |
Erster |
Schluss |
|
SANOFI SA INHABER EO 2 |
920657 |
Frankfurt |
87,190 |
20.06.24 14:37:46 |
+0,130 |
+0,15% |
0,000 |
0,000 |
86,860 |
87,060 |
|
REGENERON PHARMAC.DL-,001 |
881535 |
Frankfurt |
968,400 |
20.06.24 17:20:37 |
+4,600 |
+0,48% |
0,000 |
0,000 |
966,200 |
963,800 |